சர்வதேச பத்திரங்கள் அடையாளம் எண் க்கு தி அலெக்சியன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச பத்திரங்கள் அடையாளம் எண் க்கு தி அலெக்சியன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச பத்திரங்கள் அடையாளம் எண் க்கு தி அலெக்சியன் Today - Breaking & Trending Today

Näringsliv Börs

12 december 2020 kl 13:59
Greater scientific presence in immunology by adding Alexion s innovative complement-technology platforms and strong pipeline
Dedicated rare disease unit to be headquartered in Boston
Geographical presence to be enhanced with broad coverageacross primary, speciality and highly specialised care
Double-digit revenue growth through 2025; acquisition strengthens AstraZeneca s broad-based revenue and the company will further globalise Alexion s portfolio
Enhanced operating margin and cash flow to enable rapid debt reduction with an ambition to increase the dividend
The acquisition will be immediately core earnings-accretive andvalue-enhancing, and is aligned with stated capital-allocation priorities
AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. ....

United States , United Kingdom , City Of , Astrazeneca Adss , Rosen Katz , Ludwig Hantson , Chris Stevo , Freshfields Bruckhaus Deringer , Pascal Soriot , Tanisha Carino , Jp Morgan Cazenove , Ellen Chiniara , Megan Goulart , Brian Goff , Indrani Franchini , Morgan Stanley , Company On Twitter , Prudential Regulation Authority , Goldman Sachs , York State Department Of Financial Services , Morgan Stanley Bank International , Goldman Sachs International , Neither Goldman Sachs International , Morgan Stanley Co , London Stock Exchange , Goldman Sachs Bank United States ,

AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

Press release content from Business Wire. The AP news staff was not involved in its creation.
AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development
December 12, 2020 GMT
CAMBRIDGE, England & BOSTON (BUSINESS WIRE) Dec 12, 2020
AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion.
Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. Based on AstraZeneca’s reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or $175 per share. ....

United States , United Kingdom , City Of , Astrazeneca Adss , Rosen Katz , Ludwig Hantson , Chris Stevo , Freshfields Bruckhaus Deringer , Pascal Soriot , Tanisha Carino , Jp Morgan Cazenove , Ellen Chiniara , Megan Goulart , Brian Goff , Indrani Franchini , Adrian Kemp , Morgan Stanley , Prudential Regulation Authority , Goldman Sachs , York State Department Of Financial Services , Morgan Stanley Bank International , Goldman Sachs International , Company On Twitter Astrazeneca , Neither Goldman Sachs International , Morgan Stanley Co , London Stock Exchange ,